DUBLIN — Research and Markets has announced the addition of the “Prostate Cancer Vaccines and Therapeutic Antibodies: Pipeline – 2011” report to their offering. The prostate cancer immunotherapy pipeline is showing rapid development. Currently, there are 30 candidates in the pipeline (16 vaccines and 14 therapeutic antibodies), and one prostate cancer vaccine (Provenge) has recently […]